Maidenhead, England (ots/PRNewswire) - - Data Presented at the 18th EADV Congress add to the Comprehensive Long-Term Data set as Enbrel Reaches Five-Year Anniversary in Treating Patients With Plaque Psoriasis in Europe Data signalling that Enbrel(R) (etanercept) can improve the quality of life for people ...
Maidenhead, England (ots/PRNewswire) - Wyeth Europa, a division of Wyeth (NYSE:WYE), announced today that it has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) recommending the approval of the mTOR (mammalian target of rapamycin) ...
Maidenhead, England (ots/PRNewswire) - - My Day for RA Launches Across Europe Today: A Novel 'Goal-Centred' Patient Programme Recognising that rheumatoid arthritis (RA) can cause deformity, disability and loss of independence without effective management - My Day for RA, a new educational programme, ...
Maidenhead, England (ots/PRNewswire) - - For the First Time, Children and Adolescents in Europe With Psoriasis are now Able to Benefit From Same Efficacy and Disease Control as Adults The European Commission today granted marketing authorisation of the use of Enbrel(R) (etanercept) as the first biologic ...